A
PLRX icon

AlphaQuest’s Pliant Therapeutics PLRX Stock Holding History

AlphaQuest’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,716
Closed -$14.3K – 1522
2025
Q4 		$14.3K Hold
11,716
– – ﹤0.01% 2131
2025
Q3 		$17.3K Hold
11,716
– – ﹤0.01% 2107
2025
Q2 		$13.6K Hold
11,716
– – ﹤0.01% 1833
2025
Q1 		$15.8K Buy
11,716
+5,035
+75% +$30.6K ﹤0.01% 1741
2024
Q4 		$88K Sell
6,681
-18,890
-74% -$258K 0.01% 1133
2024
Q3 		$287K Sell
25,571
-6,604
-21% -$82.6K 0.03% 913
2024
Q2 		$346K Buy
32,175
+13,877
+76% +$179K 0.05% 595
2024
Q1 		$273K Buy
18,298
+16,247
+792% +$268K 0.05% 553
2023
Q4 		$37.1K Buy
+2,051
New +$31.2K 0.01% 914

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

AlphaQuest's PLRX Position: Q1 2026 in Review

AlphaQuest sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 11,716 shares — an estimated $14.3K sold.

AlphaQuest first reported a position in PLRX in Q4 2023 and held it in 9 quarters. The position peaked at $346K in Q2 2024. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • AlphaQuest reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 11,716 Pliant Therapeutics shares in Q1 2026, an estimated $14.3K.
  • AlphaQuest first reported a position in Pliant Therapeutics in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Pliant Therapeutics position peaked at $346K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.